《企業盈喜》中聯重科(01157.HK)料中期盈利按年增長逾1.7倍
中聯重科(01157.HK)發盈喜,預期今年首六個月的淨利潤將按年增長171.71%至212.42%,至24億至27億元人民幣。基本每股盈利介乎0.31至0.34元人民幣。
公司解釋,這是由於國內房地產和基建等下游行業需求走強,工程機械行業持續復蘇、市場需求旺盛,公司混凝土設備、起重設備等產品訂單和銷量持續保持高速增長;公司核心產品混凝土泵車、塔式起重機、工程起重機等4.0系列產品市場覆蓋率增加,市場競爭力進一步加強;以及公司繼續嚴控各項成本費用,2019年上半年銷售規模增長,費用率同比下降較快等原因所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.